blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3202787

EP3202787 - HUMAN ANTIGEN BINDING PROTEINS THAT BIND BETA-KLOTHO, FGF RECEPTORS AND COMPLEXES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.04.2021
Database last updated on 03.10.2024
FormerThe patent has been granted
Status updated on  08.05.2020
FormerGrant of patent is intended
Status updated on  19.12.2019
FormerExamination is in progress
Status updated on  12.11.2019
FormerGrant of patent is intended
Status updated on  01.07.2019
FormerExamination is in progress
Status updated on  29.06.2018
FormerRequest for examination was made
Status updated on  07.07.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, California 91320-1799 / US
[2019/31]
Former [2017/32]For all designated states
Amgen, Inc
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
Inventor(s)01 / HU, Shaw-Fen Sylvia
986 Lynnmere Drive
Thousand Oaks, CA 91360 / US
02 / FOLTZ, Ian
2108 Knightswood Place
Burnaby, BC V5A 4B9 / CA
03 / KING, Chadwick T.
1325 Moody Avenue
North Vancouver, BC V7L 3T5 / CA
04 / LI, Yang
1142 Cuesta Drive
Mountain View, CA 94040 / US
05 / ARORA, Taruna
291 Whiteclem Way
Palo Alto, CA 94306 / US
 [2017/32]
Representative(s)Altmann Stößel Dick Patentanwälte PartG mbB
Theodor-Heuss-Anlage 2
68165 Mannheim / DE
[N/P]
Former [2020/24]Altmann Stößel Dick Patentanwälte PartG mbB
Dudenstrasse 46
68167 Mannheim / DE
Former [2017/32]Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
Application number, filing date16207166.603.12.2010
[2017/32]
Priority number, dateUS20090267321P07.12.2009         Original published format: US 267321 P
US20100381846P10.09.2010         Original published format: US 381846 P
[2017/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3202787
Date:09.08.2017
Language:EN
[2017/32]
Type: B1 Patent specification 
No.:EP3202787
Date:10.06.2020
Language:EN
[2020/24]
Search report(s)(Supplementary) European search report - dispatched on:EP21.06.2017
ClassificationIPC:C07K16/18, C07K16/28, A61K39/395, A61P3/04, C07K19/00, C07K14/71
[2017/32]
CPC:
C07K16/2863 (EP,IL,US); C07K16/28 (KR,US); A61K38/17 (KR);
A61K38/18 (KR); A61K39/395 (KR); A61K47/42 (KR);
A61K48/00 (KR); A61K49/16 (KR); A61P1/16 (EP);
A61P29/00 (EP); A61P3/00 (EP); A61P3/04 (EP);
A61P3/06 (EP); A61P3/08 (EP); A61P3/10 (EP);
A61P43/00 (EP); A61P9/00 (EP); C07K14/435 (KR);
C07K14/475 (KR); C07K14/71 (EP,IL,US); C07K16/18 (EP,IL,KR,US);
C07K16/22 (KR); C07K16/40 (US); A61K2039/505 (EP,IL,US);
C07K2317/21 (EP,IL,US); C07K2317/24 (US); C07K2317/32 (EP,IL,US);
C07K2317/34 (US); C07K2317/53 (US); C07K2317/54 (US);
C07K2317/55 (US); C07K2317/56 (EP,IL,US); C07K2317/565 (EP,IL,US);
C07K2317/622 (US); C07K2317/626 (US); C07K2317/75 (EP,IL,US);
C07K2317/92 (EP,IL,US); C07K2319/30 (EP,IL,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/32]
TitleGerman:MENSCHLICHES ANTIGEN BINDENDE PROTEINE ZUR BINDUNG VON BETA-KLOTHO, FGF-REZEPTOREN UND KOMPLEXE DARAUS[2017/32]
English:HUMAN ANTIGEN BINDING PROTEINS THAT BIND BETA-KLOTHO, FGF RECEPTORS AND COMPLEXES THEREOF[2017/32]
French:PROTÉINES DE LIAISON À ANTIGÈNE HUMAIN QUI SE LIENT À BÊTA-KLOTHO, AUX RÉCEPTEURS DE FGF ET AUX COMPLEXES DE CEUX-CI[2017/32]
Examination procedure28.12.2016Examination requested  [2017/32]
28.12.2016Date on which the examining division has become responsible
09.02.2018Amendment by applicant (claims and/or description)
29.06.2018Despatch of a communication from the examining division (Time limit: M06)
07.01.2019Reply to a communication from the examining division
02.07.2019Communication of intention to grant the patent
12.11.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
20.12.2019Communication of intention to grant the patent
29.04.2020Fee for grant paid
29.04.2020Fee for publishing/printing paid
29.04.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP10788204.5  / EP2510009
Divisional application(s)EP20178046.7  / EP3760642
Opposition(s)11.03.2021No opposition filed within time limit [2021/20]
Fees paidRenewal fee
28.12.2016Renewal fee patent year 03
28.12.2016Renewal fee patent year 04
28.12.2016Renewal fee patent year 05
28.12.2016Renewal fee patent year 06
28.12.2016Renewal fee patent year 07
12.12.2017Renewal fee patent year 08
12.12.2018Renewal fee patent year 09
13.12.2019Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.12.2010
AL10.06.2020
AT10.06.2020
CY10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
HR10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
MC10.06.2020
MK10.06.2020
MT10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
RS10.06.2020
SE10.06.2020
SI10.06.2020
SK10.06.2020
SM10.06.2020
TR10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
[2022/32]
Former [2022/27]HU03.12.2010
AL10.06.2020
AT10.06.2020
CY10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
HR10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
MC10.06.2020
MT10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
RS10.06.2020
SE10.06.2020
SI10.06.2020
SK10.06.2020
SM10.06.2020
TR10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
Former [2021/40]AL10.06.2020
AT10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
HR10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
MC10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
RS10.06.2020
SE10.06.2020
SI10.06.2020
SK10.06.2020
SM10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
Former [2021/24]AL10.06.2020
AT10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
HR10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
RS10.06.2020
SE10.06.2020
SI10.06.2020
SK10.06.2020
SM10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
Former [2021/21]AL10.06.2020
AT10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
HR10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
RS10.06.2020
SE10.06.2020
SK10.06.2020
SM10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
Former [2021/10]AL10.06.2020
AT10.06.2020
CZ10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
HR10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
RS10.06.2020
SE10.06.2020
SK10.06.2020
SM10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
Former [2021/09]AL10.06.2020
AT10.06.2020
CZ10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
HR10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
NL10.06.2020
RO10.06.2020
RS10.06.2020
SE10.06.2020
SM10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
PT12.10.2020
Former [2021/04]AL10.06.2020
FI10.06.2020
HR10.06.2020
LT10.06.2020
LV10.06.2020
NL10.06.2020
RS10.06.2020
SE10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
Former [2021/01]FI10.06.2020
HR10.06.2020
LT10.06.2020
LV10.06.2020
RS10.06.2020
SE10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
Former [2020/51]FI10.06.2020
HR10.06.2020
LT10.06.2020
LV10.06.2020
RS10.06.2020
SE10.06.2020
NO10.09.2020
GR11.09.2020
Former [2020/50]FI10.06.2020
HR10.06.2020
LT10.06.2020
LV10.06.2020
SE10.06.2020
NO10.09.2020
GR11.09.2020
Former [2020/48]FI10.06.2020
LT10.06.2020
SE10.06.2020
NO10.09.2020
Former [2020/47]LT10.06.2020
NO10.09.2020
Documents cited:Search[A]WO2005037235  (IMCLONE SYSTEMS INC [US], et al);
 [A]US2007293430  (FRYE CHRISTOPHER C [US], et al);
 [IA]WO2008123625  (NAT INST OF ADVANCED IND SCIEN [JP], et al);
 [IPA]US2010184665  (SUZUKI MASASHI [JP], et al);
by applicantUS3773919
 EP0036676
 EP0058481
 US4399216
 EP0088046
 EP0133988
 EP0143949
 WO8705330
 US4740461
 US4751180
 US4816567
 US4912040
 WO9004036
 EP0367566
 US4935233
 US4946778
 US4959455
 US4965195
 US4968607
 US5011912
 WO9110741
 EP0460846
 WO9203918
 WO9215673
 WO9222646
 WO9301227
 WO9310151
 EP0546073
 US5262522
 WO9402602
 US5292658
 WO9410308
 WO9507463
 US5418155
 US5426048
 US5457035
 US5530101
 US5545807
 US5545806
 US5569825
 WO9633735
 US5585089
 US5625126
 US5633425
 US5661016
 EP0546073
 US5683888
 US5693762
 US5693761
 WO9814605
 US5741668
 WO9824893
 WO9826277
 US5770429
 US5777079
 US5789650
 US5804387
 US5814318
 US5874299
 US5874304
 US5877293
 US5877397
 US5876995
 WO9910494
 US5886152
 US5925558
 WO9949019
 WO0009560
 US6054297
 US6162963
 WO0076310
 US6180370
 US6255458
 US6270964
 US6300129
 US2003039958
 US6673986
 US2004009507
 US6696245
 US2004038291
 US6713610
 US2004202995
 US6846634
 US2005202512
 WO1993US00829
 WO1994US01875
 US19960759620
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.